Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-08-10

Clinical Trial Update: Cognitive Remediation in 22q11DS [NA]

View source ↗

Summary

A completed clinical trial evaluating cognitive remediation in individuals with 22q11.2 Deletion Syndrome (Velo-Cardio-Facial Syndrome).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Duke University | Conditions: 22q11.2 Deletion Syndrome, Velo-Cardio-Facial Syndrome | NA | Status: COMPLETED